Cargando…
Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor
Canine cognitive dysfunction (CCD) is common in aged dogs and has many similarities with Alzheimer’s disease. Unfortunately, like Alzheimer’s disease, CCD cannot be cured. In the present study, we treated dogs with CCD with our newly developed and characterized butyrylcholinesterase inhibitor (BChEi...
Autores principales: | Zakošek Pipan, Maja, Prpar Mihevc, Sonja, Štrbenc, Malan, Košak, Urban, German Ilić, Ilija, Trontelj, Jurij, Žakelj, Simon, Gobec, Stanislav, Pavlin, Darja, Majdič, Gregor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438013/ https://www.ncbi.nlm.nih.gov/pubmed/34518582 http://dx.doi.org/10.1038/s41598-021-97404-2 |
Ejemplares similares
-
Nitrosative Stress in the Frontal Cortex From Dogs With Canine Cognitive Dysfunction
por: Prpar Mihevc, Sonja, et al.
Publicado: (2020) -
Canine Cognitive Dysfunction and Alzheimer’s Disease – Two Facets of the Same Disease?
por: Prpar Mihevc, Sonja, et al.
Publicado: (2019) -
Development of an in-vivo active reversible butyrylcholinesterase inhibitor
por: Košak, Urban, et al.
Publicado: (2016) -
Neural differentiation of canine mesenchymal stem cells/multipotent mesenchymal stromal cells
por: Prpar Mihevc, Sonja, et al.
Publicado: (2020) -
Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes
por: Pajk, Stane, et al.
Publicado: (2020)